EUVIMEDEUVIMED entdecken
Crossref

Self‐Accelerated Nanoregulators for Positive Feedback Ferroptosis‐Immunotherapy

Xu Zhang, Xinlu Zhang, Qin Fan, Jiansen Li, Shitian Jia, Xiaoyuan Chen iD, Sheng Wang

Small · 2025

DOI: 10.1002/smll.202408156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Xu Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Faculty of Medicine, Tianjin University, Tianjin, 300072, P. R. China. Hauptthemen laut MEDLINE: Ferroptosis, Immunotherapy, Nanoparticles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activating specific immunity through intelligent delivery of chemotherapeutic drugs shows great potential for effective tumor therapy. However, conventional tumor microenvironment‐responsive nanomedicines are often difficult to achieve both specificity and sensitivity, leading to severe adverse effects or limited drug release efficiency. Furthermore, the immunosuppressive microenvironment of tumor will also seriously restrict the treatment efficacy. In this work, a cascade‐responsive multi‐polyprodrug nanoregulator is developed. Under the tumor microenvironment with high hydrogen peroxide level, the nanoregulators can simultaneously release chemotherapeutic drugs (doxorubicin), indoleamine 2,3‐dioxygenase 1 inhibitor (1‐methyl‐tryptophan) and cinnamaldehyde in a self‐accelerating manner. The combination of reactive oxygen species‐induced ferroptosis and doxorubicin‐induced apoptosis can synergistically enhance immunogenic cell death and activate the immune response. The released1‐methyl‐tryptophan can promote cytotoxic T lymphocyte activation and reduce immune escape by inhibiting the tryptophan conversion. Meanwhile, it also enhances ferroptosis by inhibiting reactive oxygen species scavenging and cystine/glutamate antiporter expression, achieving the positive feedback ferroptosis‐immunotherapy. This work provides a self‐accelerated drug delivery strategy and a potential cooperation mode for tumor synergistic immunotherapy based on ferroptosis‐apoptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisImmunotherapyNanoparticlesAnimalsReactive Oxygen SpeciesHumansDoxorubicinTryptophanTumor MicroenvironmentMiceCell Line, TumorApoptosis

Stichwörter der Autor:innen

IDO inhibitioncascaded responsesferroptosisimmunotherapynanomedicine

Substanzen

Reactive Oxygen SpeciesDoxorubicinTryptophan

Autor:innen und Institutionen

  • School of Life Sciences, Faculty of Medicine, Tianjin University, Tianjin, 300072, P. R. China.
  • Department of Diagnostic Radiology, Department of Chemical and Biomolecular Engineering, Department of Biomedical Engineering, Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore, Singap…
  • Department of Chemical and Biomolecular Engineering, College of Design and Engineering, National University of Singapore, Singapore, 117575, Singapore.
  • Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore, 117575, Singapore.
  • Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, National University of Singapore, Singapore, 117544, Singapore.
  • Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.

ORCID-Profile: Xiaoyuan Chen

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • China Postdoctoral Science Foundation
  • Tianjin Joint Support Program
  • Postdoctoral Fellowship Program of CPSF
  • National Medical Research Council
  • National Research Foundation
  • National University of Singapore

Zitieren

APA

Zhang, X., Zhang, X., Fan, Q., Li, J., Jia, S., Chen, X., & Wang, S. (2025). Self‐Accelerated Nanoregulators for Positive Feedback Ferroptosis‐Immunotherapy. Small. https://doi.org/10.1002/smll.202408156

Vancouver

Zhang X, Zhang X, Fan Q, Li J, Jia S, Chen X, et al. Self‐Accelerated Nanoregulators for Positive Feedback Ferroptosis‐Immunotherapy. Small. 2025. doi:10.1002/smll.202408156

BibTeX
@article{Zhang2025,
  author = {Zhang, Xu and Zhang, Xinlu and Fan, Qin and Li, Jiansen and Jia, Shitian and Chen, Xiaoyuan and Wang, Sheng},
  title = {Self‐Accelerated Nanoregulators for Positive Feedback Ferroptosis‐Immunotherapy},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202408156}
}
Kostenlos starten →